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Abstract – We explored direct dehydrative coupling of tetrahydro- 
2H-pyran-2,3-diol or a 1,2-dihydroxy sugar with various alcohols using a range of 
arylboronic acids. Among the catalysts, 2-borono-4-trifluoromethylbenzoic acid 
efficiently promoted acetalization of tetrahydro-2H-pyran-2,3-diol. 
Ferroceniumboronic acid showed the best catalytic activity for glycosylation of 
the 1,2-dihydroxy sugar. The major products were 1,2-cis-α-D-glucopyranosides.
 
INTRODUCTION 
Glycosylation is a key step for the synthesis of oligosaccharides and glycopeptides with a range of 
biological activities.1 Although there have been many reports on the glycosidic bond-forming reaction, 
new efficient synthetic methods remain to be explored from the perspectives of atom-economy, 
sustainability, yield, and selectivity. In the conventional glycosylation, glycosyl donors with acyloxy, 
alkylthio, halogen, 2,2,2-trichloro-1-iminoethoxy, and pent-4-enyloxy groups at the anomeric position are 
required for coupling with a free hydroxy group of a glycosyl acceptor in the presence of an appropriate 
Brønsted acid or Lewis acid (Scheme 1a).2 The activated glycosyl donors are generally not stable and 
need to be prepared and stored with care. Furthermore, glycosylation sometimes requires more than the 
stoichiometric amount of activator or additive and cooling or heating of the reaction mixture to attain a 
high yield and α/β-selectivity. To overcome these limitations, we planned to investigate catalytic 
dehydrative glycosylation of 1,2-dihydroxy sugars as inactivated glycosyl donors in the presence of 
arylboronic acids3 as catalysts (Scheme 1b). 
 
  
Scheme 1. New concept for glycosylation 
 
To achieve this type of glycosylation (Scheme 2), we envisioned that the boronate ester D, generated 
from electron-deficient arylboronic acid B1 (X = electron withdrawing group) and 1,2-dihydroxy sugar A, 
would form borate complex E via coordination of glycosyl acceptor C. Successive intramolecular 
migration of the coordinated sugar C (RO–) to an oxocarbenium ion intermediate (E → F) and ligand 
exchange of F with diol A would provide the desired glycoside G with 1,2-cis-α-selectivity. Alternatively, 
using arylboronic acid B2 bearing an acidic moiety (Y–H) at the ortho-position, the anomeric C–O bond 
of the obtained boronate ester H would cleave through activation by an intramolecular hydrogen-bonding 
interaction. Then, glycosyl acceptor C would attack the anomeric carbon of the resulting intermediate I 
from the bottom side with assistance from the conjugate base (Y–). After ligand exchange of J with diol A, 
this would also give G as the predominant product.  
 
 
Scheme 2. Glycosylation of 1,2-dihydroxy sugar A catalyzed by arylboronic acids B1 and B2 
 
Glycosylation of 1-hydroxy sugars usually requires a stoichiometric amount of dehydrating reagent,4 and 
only a few catalytic dehydrative reactions have been reported.5,6 To date, the catalytic system 
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 Sn(OTf)2/Me3SiCl/LiClO4 has been identified as the best combination of catalyst and additive for 
α-selective glycosylation. In this paper, we describe arylboronic acid-catalyzed dehydrative coupling of a 
1,2-dihydroxyglycosyl donor with several alcohols for the synthesis of 1,2-cis-α-D-glucopyranosides. 
RESULTS AND DISCUSSION 
We first examined the reaction of phenylboronic acid and cyclic 1,2-diol (Scheme 3).7 A 1:1 mixture of 
phenylboronic acid and tetrahydro-2H-pyran-2,3-diol 1 (cis:trans = 0.8:1) was stirred in CDCl3 at room 
temperature for 10 min. The corresponding phenylboronate ester 2 was obtained as the only product. The 
same treatment of 3,4,6-tri-O-benzyl-D-glucopyranose 3 (α:β = 1:1) with phenylboronic acid at 40 °C for 
6 h provided the cis-bicyclic boronate ester 4 exclusively. The configurations of 2 and 4 were determined 
to be cis by NOESY of the crude products. We were unable to isolate these boronates because they were 
not stable on silica gel. 
 
 
Scheme 3. Formation of boronate esters 2 and 4 from phenylboronic acid and 1,2-diols 1 and 3 
 
Having confirmed the formation of boronate ester as a reaction intermediate, we next turned our attention 
to acetalization of model compound 1 with benzyl alcohol in the presence of a range of arylboronic acids 
containing electron-deficient functional groups (Scheme 4a). Commercially available boronic acids 6–8 
were inefficient for the acetalization of 1, and did not give the desired products 5. After screening many 
catalysts, we found that ferroceniumboronic acids 9a and 9b, which were readily prepared from 
ferroceneboronic acid and silver salts (AgSbF6 and AgOTf),8 showed moderate catalytic activity to 
produce benzyl acetals 5 in 29% (9a) and 34% (9b) yields as a mixture of C2-isomers (cis:trans = 34:66 
for 9a and 37:63 for 9b).  
Thus, we examined bifunctional arylboronic acids 10–13 to improve the yields of benzyl acetals 5 
(Scheme 4b). In contrast to the result with phenol 11, ortho-carboxylic acid 10a9 gave a better yield of 5 




1 (cis:trans = 0.8:1)




























 nitromethane dramatically improved both the yield and stereoselectivity of 5 (87%, cis:trans = 58:42) 
compared with the reactions of 10a and 10b in acetonitrile. These results suggest that the ortho-carboxy 
group plays a crucial role in the synergistic activation of the anomeric C–O bond of the presumed 
boronate ester 2. This synergistic effect of boronic acid and carboxylic acid was further supported by the 
fact that neither dual catalysis with phenylboronic acid and benzoic acid nor use of meta- and 
para-substituted carboxylic acids 12 and 13 exhibited any catalytic activity. 
 
 
Scheme 4. Screening of arylboronic acids for the acetalization of 1 and BnOH 
 
To determine what type of active arylboronic acid, 9 or 10, was best for the acetalization, the reaction of 
3,4,6-tri-O-benzyl-D-glucopyranose 3 with methanol in nitromethane was carried out in the presence of 
9a, 9b, or 10b (Table 1). Unexpectedly, the pre-prepared ferroceniumboronic acid 9a showed the best 
catalytic performance, producing a 69:31 mixture of α-14a and β-14a in 78% yield (entries 1–3). By 
contrast, both 9b and 10b resulted in low yields of a mixture of α/β-14a. Next, we examined the reaction 
using ferroceniumboronic acids 9a and 9b prepared in situ from ferroceneboronic acid 8 and silver salts 
(entries 4 and 5). Catalysts 9a and 9b led to slight and significant decreases in the yield, respectively, 
probably because of formation of short-lived chemical species. However, the yield of 14a improved to 
82% and the reaction time decreased to 24 h when 20 mol% of AgSbF6 was added to a solution of 

















9a (X = SbF6): 29% (34:66)a























(b) Screening of bifunctional arylboronic acids
10a (R = H): 44% (42:58)a
10b (R = CF3): 63% (35:65)a
10b (R = CF3)b: 87% (58:42)a
10c (R = OMe): 35% (47:53)a
a) The values in parenthesis indicate a ratio of cis-5 and trans-5.
b) The reaction was carried out in MeNO2 instead of MeCN.
R
+ −
 effect using 1,2-dichloroethane, ether, and THF, and found that only 1,2-dichloroethane could be used as 
an alternative solvent (entries 8–10).  
 
Table 1. Optimization of the reaction conditions for glycosylation of 3 
 
Entry Cat. Additive (x mol%) Solvent Time (h) Yield (%) Ratio (α:β) 
1 9a  MeNO2 48 78 69:31 
2 9b  MeNO2 48 12 59:41 
3 10b  MeNO2 48 9 53:47 
4 8a  AgSbF6 (10) MeNO2 48 70 53:47 
5 8a  AgOTf (10) MeNO2 48 trace  
6 8b AgSbF6 (10) MeNO2 48 15 31:69 
7 8b AgSbF6 (20) MeNO2 24 82 62:38 
8 8b AgSbF6 (20) 1,2-DCE 48 82 61:39 
9 8b AgSbF6 (20) Et2O 48 37 51:49 
10 8b AgSbF6 (20) THF 48 27 48:52 
a Catalyst 9a or 9b was prepared in situ by mixing 8 and the additive in MeNO2, and then adding 3 and 
MeOH. 
b Catalyst 9a was prepared in situ by mixing the additive with a solution of 8, 3, and MeOH. 
 
Although further enhancement of α/β-selectivity is needed, we evaluated the scope of the nucleophile 
under the optimized conditions. The established reaction with 3 could be applied to several primary 
alcohols, such as ethanol, propargyl alcohol, and 4-chlorobenzyl alcohol, to give the corresponding 
glucosides 14b–d in 72%–88% yields with moderate α/β-selectivity (51:49 to 66:34) (Table 2). 
Secondary alcohols such as 2-propanol and cyclohexanol were also introduced into diol 3, and gave the 
desired products 14e and 14f with good selectivities (α:β = 74:26–81:19). Notably, dehydrative 
glycosylation of diol 3 with methyl-2,3,4-tri-O-benzyl-α-D-glucopyranoside 15 took place smoothly 


























 Table 2. Scope of the nucleophile under the optimized conditions 
 
 
Although we obtained the corresponding glycosides 14a–g in reasonable yields, the α/β-selectivity was 
highly dependent on the alcohols used. To clarify the stereodetermining factor of the glycosylation, 
epimerization experiment of α-14e and β-14e was carried out under the optimized conditions (Scheme 5). 
To our surprise, the same treatment of α-14e or β-14e with ferroceneboronic acid 8 and AgSbF6 in the 
presence of 2 equiv of 2-propanol resulted in a mixture of α-14e and β-14e in a similar ratio. These 
results suggest that the two products, α-14 and β-14, are interconvertible under the conditions and that the 
α:β ratio is controlled thermodynamically. We suspect that any acidic species might be generated in the 
reaction mixture by the reaction of ferroceneboronic acid 8 and the silver salt. 
 
 
Scheme 5. Epimerization experiment of α-14e and β-14e 
 
In conclusion, we developed a new catalytic method for dehydrative acetalization of 
tetrahydro-2H-pyran-2,3-diol using highly electron-deficient boronic acid 9a and bifunctional arylboronic 
acid 10b. In addition, in situ generation of ferroceniumboronic acid 9a gave the best catalysis for 
dehydrative glycosylation. Catalytic dehydrative coupling of diol donor 3 and glucoside 15 was 






































































HO Oi-Pri-PrOH (2.0 equiv)














14e (α:β = 70:30)
 α/β-selectivity need to be improved. Further synthetic and mechanistic studies are underway in our 
laboratory. 
EXPERIMENTAL 
Unless otherwise noted, all chemicals and solvents were obtained from commercial suppliers and used 
without further purification. Analytical thin-layer chromatography was performed with Merck Silica gel 
60. Column chromatography was performed on Cica silica gel 60 (spherical/40–100 µm). Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded with a JEOL JNM-AL 400 at 400 MHz, JEOL 
JNM-ECA 500 at 500 MHz, or Avance I 600 (Bruker Biospin AG, Switzerland) at 600 MHz. Chemical 
shifts are reported relative to TMS (δ 0.00) or CD3OD (δ 3.30). Multiplicity is indicated by one or more of 
the following: s (singlet); d (doublet); dd (doublet of doublets); t (triplet); q (quartet); m (multiplet); br 
(broad). Carbon nuclear magnetic resonance (13C NMR) spectra were recorded with a JEOL JNM-AL 400 
at 100 MHz, JEOL JNM-ECA 500 at 125 MHz, or Avance I 600 (Bruker Biospin AG, Switzerland) at 
150 MHz. Chemical shifts are reported relative to CDCl3 (δ 77.0) or CD3OD (δ 49.0). Infrared spectra 
were recorded on a JASCO FT/IR-4100. High resolution mass spectra were obtained on a Shimadzu 
LCMS-IT-TOF for ESI-MS. Optical rotations were recorded on a JASCO P-2200 polarimeter; 
concentrations are quoted in grams per 100 mL. Unless otherwise noted, all materials and solvents were 
purchased from Tokyo Kasei Co., Aldrich Inc., and other commercial suppliers and were used without 
purification. 
 
Preparation of starting materials 
Compounds 110 and 310 are known compounds. 
Tetrahydro-2H-pyran-2,3-diol (1): To a solution of mCPBA (15 mmol, 3.45 g) in Et2O (50 mL) were 
added 3,4-dihydro-2H-pyran (10 mmol, 0.905 mL) and H2O (5 mL) at 0 °C under argon atmosphere. The 
solution was stirred at 0 °C for 19 h before concentrated. Then, the mixture containing colorless 
precipitates was filtered through a glass filter using cold H2O. After the filtrate was coevaporated with 
toluene, the crude was purified by column chromatography (EtOAc) to provide 1 (861 mg, 73%, cis:trans 
= 0.8:1) as a colorless oil; 1H NMR (500 MHz, CDCl3, 40:60 mixture of anomers): δ 4.92 (s, 1.0H), 4.51 
(d, J = 5.7 Hz, 0.6H), 4.42 (s, 0.4H), 3.97−3.90 (m, 1.0H), 3.69 (s, 0.6H), 3.55−3.40 (m, 2.2H), 2.89 (s, 
0.4H), 2.10−2.07 (m, 0.6H), 1.90−1.46 (m, 3.2H); 13C NMR (125 MHz, CDCl3, 40:60 mixture of 




 Formation of boronic esters (2 and 4) (Scheme 3) 
The compound 1 (11.8 mg, 0.10 mmol) and phenylboronic acid (12.2 mg, 0.10 mmol) were dissolved in 
CDCl3 (0.50 mL), respectively, and both solutions were mixed at room temperature. The resulting 
solution was transferred to a NMR tube for taking the following spectral data; 1H NMR (500 MHz, 
CDCl3): δ 7.89 (d, J = 7.4 Hz, 2H), 7.52 (dd, J = 7.4, 7.4 Hz, 1H), 7.41 (dd, J = 7.7, 7.4 Hz, 2H), 5.81 (d, 
J = 5.7 Hz, 1H), 4.57 (dt, J = 5.7, 3.7 Hz, 1H), 3.82 (dt, J = 11.7, 6.9 Hz, 1H), 3.73 (dt, J = 11.7, 6.6 Hz, 
1H), 2.10−2.04 (m, 1H), 1.94−1.86 (m, 1H), 1.78−1.72 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 135.6, 
135.0, 131.8, 127.9, 98.5, 73.5, 58.0, 22.3, 16.5. 
The compound 3 (22.5 mg, 0.050 mmol) and phenylboronic acid (6.1 mg, 0.050 mmol) were dissolved in 
CDCl3 (0.50 mL), respectively. Both solutions were mixed, and stirred at 40 °C for 6 h. The resulting 
solution was transferred to a NMR tube for taking the following spectral data; 1H NMR (500 MHz, 
CDCl3): δ 7.77 (d, J = 6.9 Hz, 2H), 7.42 (t, J = 8.3 Hz, 1H), 7.33−7.17 (m, 15H), 7.08 (t, J = 3.7 Hz, 2H), 
5.99 (d, J = 5.7 Hz, 1H), 4.74 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 11.5 Hz, 1H), 4.56 (d, J = 11.5 Hz, 1H), 
4.52−4.50 (m, 2H), 4.43 (d, J = 12.6 Hz, 1H), 4.34 (d, J = 11.5 Hz, 1H), 3.84 (t, J = 4.3 Hz, 1H), 3.70 (d, 
J = 3.4 Hz, 2H), 3.61 (d, J = 2.3 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 137.9, 137.8, 135.6, 135.1, 
132.0, 128.5, 128.3 (2C), 128.0, 127.9, 127.8 (2C), 127.6 (2C), 99.1, 80.3, 77.1, 74.5, 73.4, 73.0, 72.3, 
70.4, 69.1. 
Preparation of arylboronic acids (9 and 10) 
Catalysts 6, 7, 8, and 10a are commercially available. The known catalysts 9a8 and 10b9 were prepared 
according to the reported procedure. 
Ferroceniumboronic acid trifluoromethanesulfonate salt (9b): The title compound (107 mg, 65%) 
was prepared as dark green solids by a similar method as described in the literature,8 starting from 
ferroceneboronic acid (100 mg, 0.435 mmol) and AgOTf (112 mg, 0.435 mmol). The 1H and 13C NMR 
spectra were not able to obtain in high quality due to the paramagnetism of iron (III). 19F NMR (376 MHz, 
acetone-d6): δ −72.3 (br s, 3F); IR (ATR): 3399, 3112, 1656, 1418, 1225, 1164, 1025 cm-1; HRMS (ESI) 
calcd for C11H13O2BFe [M−OTf−H2O+CH3OH]+: 244.0355; Found: 244.0362; calcd for C12H15O2BFe 
[M−OTf−2H2O+2CH3OH]+: 258.0512; Found: 258.0517; calcd for CO3F3S [M−C10H11O2BFe]–: 
148.9526; Found: 148.9530. 
2-Borono-4-methoxybenzoic acid (10c): The title compound (139 mg, 31%) was obtained as an ivory 
solid according to the literature,9 starting from tert-butyl 4-methoxybenzoate (469 mg, 2.2 mmol); 1H 
NMR (500 MHz, CD3OD): δ 7.89 (d, J = 8.6 Hz, 1H), 6.95 (dd, J = 8.6, 2.3 Hz, 1H), 6.91 (d, J = 2.3 Hz, 
1H), 3.85 (s, 3H); 13C NMR (125 MHz, CD3OD): δ 172.1, 164.8, 132.1, 131.2, 127.0, 116.2, 114.8, 55.9; 
 IR (ATR): 3201, 1596, 1463, 1286, 1242, 1148, 1086, 869 cm-1; HRMS (ESI) calcd for C10H12O5B 
[M−2H2O+2CH3OH−H] –: 223.0785; Found: 223.0783. 
General procedure for the synthesis of benzyl acetals (5) with arylboronic acids (6−13) (Scheme 4) 
Both cis-511 and trans-512 are known compounds, but their 13C NMR spectral data have not been reported. 
2-(Benzyloxy)tetrahydro-2H-pyran-3-ol (cis-5 and trans-5): To a mixture of 1 (0.10 mmol, 11.8 mg) 
and catalyst (0.010 mmol) in MeCN (1.0 mL) was added BnOH (0.30 mmol, 31 µL). The reaction 
mixture was stirred at 40 °C for 48 h, before concentrated. The crude was purified by column 
chromatography (hexane/EtOAc = 3:1) to provide a mixture of cis-5 and trans-5 as a colorless oil. 
cis-5: 1H NMR (400 MHz, CDCl3): δ 7.37−7.30 (m, 5H), 4.82 (d, J = 11.0 Hz, 1H), 4.81 (d, J = 2.9 Hz, 
1H), 4.53 (d, J = 11.0 Hz, 1H), 3.73 (td, J = 10.4, 3.9 Hz, 1H), 3.66−3.64 (m, 1H), 3.55−3.52 (m, 1H), 
2.02 (br s, 1H), 1.87−1.67 (m, 4H); 13C NMR (100 MHz, CDCl3): δ 137.6, 128.4, 127.9, 127.8, 97.7, 69.2, 
68.0, 59.9, 27.7, 24.1.  
trans-5: 1H NMR (400 MHz, CDCl3): δ 7.37−7.30 (m, 5H), 4.86 (d, J = 11.6 Hz, 1H), 4.55 (d, J = 11.6 Hz, 
1H), 4.38 (d, J = 5.8 Hz, 1H), 3.97−3.92 (m, 1H), 3.56−3.47 (m, 2H), 2.35 (br s, 1H), 2.11−2.03 (m, 1H), 
1.79−1.49 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 137.5, 128.4, 128.0, 127.8, 102.3, 69.9, 68.5, 63.7, 
28.0, 22.9. 
General procedure for the synthesis of methyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14a) (Table 1) 
Both α-14a13 and β-14a14 are known and their spectral data were identical to the reported data of the 
authentic samples. 
(Method A in entries 1−3) The reaction was performed in MeNO2 according to the procedure for the 
synthesis of 5, giving a mixture of α-14a and β-14a. 
(Method B in entries 4−5) A mixture of 8 (0.010 mmol) and AgSbF6 or AgOTf (0.010 mmol) in MeNO2 
(0.10 mL) was stirred at room temperature for 30 min under argon atmosphere. Then, MeOH (0.30 mmol) 
and a solution of 3 (0.10 mmol) in MeNO2 (1.9 mL) were successively added, and the resulting mixture 
was stirred at 40 °C for 48 h. Then, the mixture was concentrated at 30−35 °C. The crude was purified by 
column chromatography (hexane/EtOAc = 2:1 → 1:1) to afford a mixture of α-14a and β-14a. 
(Method C in entries 6−10) To a solution of 3 (0.10 mmol), 8 (0.010 mmol), and MeOH (0.30 mmol) in 
MeNO2 (2.0 mL) was added AgSbF6 (0.010 or 0.020 mmol) in a glove box, and the reaction mixture was 
stirred at 40 °C for 24 h. Then, the reaction mixture was concentrated at 30−35 °C. The crude was 
purified by column chromatography (hexane/EtOAc = 2:1 → 1:1) to afford a mixture of α-14a and 
β-14a. 
Ethyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14b) (Entry 1 in Table 2): The reaction was performed 
according to method C for the synthesis of 14a, providing a mixture of α-14b and β-14b (34.5 mg, 72%, 
 α:β = 51:49), starting from substrate 3 (45.1 mg, 0.10 mmol) and EtOH (17.5 µL, 0.30 mmol). The 
spectral data of β-14b were identical to the reported data of the authentic sample.15 
α-14b: A colorless solid; [α]D25 +81.7 (c 1.0, CHCl3); 1H NMR (600 MHz, CDCl3): δ 7.39−7.27 (m, 13H), 
7.14 (dd, J = 7.7, 2.2 Hz, 2H), 4.94 (d, J = 11.0 Hz, 1H), 4.91 (d, J = 3.8 Hz, 1H), 4.85 (d, J = 11.0 Hz, 
1H), 4.82 (d, J = 11.0 Hz, 1H), 4.63 (d, J = 12.1 Hz, 1H), 4.51 (d, J = 12.1 Hz, 1H), 4.49 (d, J = 10.4 Hz, 
1H), 3.80−3.74 (m, 4H), 3.71 (dd, J = 9.3, 3.8 Hz, 1H), 3.67 (dd, J = 10.7, 1.9 Hz, 1H), 3.64 (t, J = 9.3 Hz, 
1H), 3.54 (dq, J = 9.3, 7.1 Hz, 1H), 2.12 (br s, 1H), 1.23 (t, J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3): 
δ 138.7, 138.2, 137.9, 128.4 (2C), 127.9 (3C), 127.7 (2C), 127.6, 98.1, 83.5, 77.4, 75.3, 75.0, 73.5, 73.0, 
70.5, 68.5, 63.5, 15.0; IR (ATR): 3455, 3030, 2911, 1453, 1361, 1273, 1043, 1027 cm-1; HRMS (ESI) 
calcd for C29H34O6Na [M+Na]+: 501.2248; Found: 501.2237. 
Propargyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14c) (Entry 2 in Table 2): The reaction was 
performed according to method C for the synthesis of 14a, providing a mixture of α-14c and β-14c (38.4 
mg, 79%, α:β = 66:34), starting from substrate 3 (45.1 mg, 0.10 mmol) and HC≡CCH2OH (17.7 µL, 0.30 
mmol). The spectral data of β-14c were identical to the reported data of the authentic sample.16 
α-14c: A colorless oil; [α]D25 +92.8 (c 0.50, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.38−7.27 (m, 13H), 
7.15 (dd, J = 7.2, 2.0 Hz, 2H), 5.10 (d, J = 2.9 Hz, 1H), 4.92 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.5 Hz, 
1H), 4.82 (d, J = 10.9 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 10.9 Hz, 
1H), 4.28 (d, J = 2.3 Hz, 2H), 3.82−3.74 (m, 4H), 3.68−3.64 (m, 2H), 2.44 (t, J = 2.3 Hz, 1H), 2.12 (d, J = 
8.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 138.6, 138.1, 137.8, 128.4 (3C), 127.9 (2C), 127.7 (2C), 
97.2, 83.1, 78.6, 77.2, 75.4, 75.0 (2C), 73.5, 72.7, 71.1, 68.3, 54.8; IR (ATR): 3546, 3286, 3030, 2922, 
2863, 1496, 1454, 1360, 1039 cm-1; HRMS (ESI) calcd for C30H32O6Na [M+Na]+: 511.2091; Found: 
511.2084. 
4-Chlorobenzyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14d) (Entry 3 in Table 2): The reaction was 
performed according to method C for the synthesis of 14a, providing a mixture of α-14d and β-14d (50.6 
mg, 88%, α:β = 61:39), starting from substrate 3 (45.1 mg, 0.10 mmol) and 4-ClC6H4CH2OH (42.8 mg, 
0.30 mmol). 
α-14d: A colorless oil; [α]D25 +64.0 (c 0.86, CHCl3); 1H NMR (600 MHz, CDCl3): δ 7.37−7.27 (m, 17H), 
7.14 (dd, J = 7.4, 1.9 Hz, 2H), 5.00 (d, J = 3.8 Hz, 1H), 4.91 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 
1H), 4.81 (d, J = 11.0 Hz, 1H), 4.70 (d, J = 12.1 Hz, 1H), 4.62 (d, J = 12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 
1H), 4.51 (d, J = 12.1 Hz, 1H), 4.49 (d, J = 12.1 Hz, 1H), 3.80−3.71 (m, 4H), 3.64 (dd, J = 9.9, 8.8 Hz, 
1H), 3.61 (dd, J = 10.7, 1.9 Hz, 1H), 2.09 (d, J = 8.8 Hz, 1H); 13C NMR (150 MHz, CDCl3): δ 138.6, 
138.0, 137.9, 135.5, 133.8, 129.5, 128.7, 128.4 (2C), 128.2, 127.9 (3C), 127.8, 127.7 (2C), 97.9, 83.3, 
 77.4, 75.4, 75.1, 73.5, 72.9, 70.9, 69.0, 68.4; IR (ATR): 3446, 3031, 2922, 1492, 1453, 1027, 1013 cm-1; 
HRMS (ESI) calcd for C34H35O6ClNa [M+Na]+: 597.2014; Found: 597.2012. 
β-14d: A colorless solid; [α]D25 −16.4 (c 1.1, CHCl3); 1H NMR (600 MHz, CDCl3): δ 7.37−7.27 (m, 17H), 
7.18 (d, J = 7.7 Hz, 2H), 4.90 (d, J = 11.5 Hz, 1H), 4.89 (d, J = 12.1 Hz, 1H), 4.83 (d, J = 11.5 Hz, 2H), 
4.62 (d, J = 12.1 Hz, 1H), 4.60 (d, J = 11.5 Hz, 1H), 4.54 (d, J = 12.1 Hz, 2H), 4.34 (d, J = 7.1 Hz, 1H), 
3.75 (d, J = 11.0 Hz, 1H), 3.70 (dd, J = 11.0, 4.4 Hz, 1H), 3.64−3.56 (m, 3H), 3.48 (dd, J = 9.9, 4.4 Hz, 
1H), 2.32 (br s, 1H); 13C NMR (150 MHz, CDCl3): δ 138.5, 138.1, 138.0, 135.7, 133.7, 129.4, 128.6, 
128.5, 128.4 (2C), 127.9 (2C), 127.8 (2C), 127.7 (2C), 101.7, 84.5, 77.5, 75.2 (2C), 75.0, 74.6, 73.5, 70.2, 
68.8; IR (ATR): 3288, 3030, 2923, 1494, 1451, 1361, 1059, 1043 cm-1; HRMS (ESI) calcd for 
C34H35O6ClNa [M+Na]+: 597.2014; Found: 597.2010. 
Isopropyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14e) (Entry 4 in Table 2): The reaction was 
performed according to method C for the synthesis of 14a, providing a mixture of α-14e and β-14e (36.5 
mg, 74%, α:β = 81:19), starting from substrate 3 (45.1 mg, 0.10 mmol) and i-PrOH (23.0 µL, 0.30 mmol). 
The spectral data of the obtained products α-14e and β-14e were identical to the reported data of the 
authentic samples α-14e17 and β-14e.14,17 
Cyclohexyl 3,4,6-tri-O-benzyl-D-glucopyranoside (14f) (Entry 5 in Table 2): The reaction was 
performed according to method C for the synthesis of 14a, providing a mixture of α-14f and β-14f (30.8 
mg, 58%, α:β = 74:26), starting from substrate 3 (45.1 mg, 0.10 mmol) and C6H11OH (31.7 µL, 0.30 
mmol). The spectral data of the obtained products α-14f and β-14f were identical to the reported data of 
the authentic samples α-14f13 and β-14f.14 
Methyl 3,4,6-tri-O-benzyl-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (14g) 
(Entry 6 in Table 2): The reaction was performed according to method C for the synthesis of 14a, 
providing a mixture of α-14g and β-14g (46.6 mg, 52%, α:β = 50:50), starting from substrate 3 (45.1 mg, 
0.10 mmol) and 15 (139 mg, 0.30 mmol). The spectral data of the obtained products α-14g and β-14g 
were identical to the reported data of the authentic samples α-14g and β-14g.18 
The epimerization experiment of α-14e and β-14e (Scheme 5): To a solution of α-14e (24.6 mg, 50 
µmol), 8 (1.1 mg, 5.0 µmol), and i-PrOH (7.7 µL, 0.10 mmol) in MeNO2 (1.0 mL) was added AgSbF6 
(3.4 mg, 10 µmol) in a glove box, and the reaction mixture was stirred at 40 °C for 48 h. Then, the 
reaction mixture was concentrated at 30−35 °C. The crude was purified by column chromatography 
(hexane/EtOAc = 3:1) to give a mixture of α-14e and β-14e (21.5 mg, 87%, α:β = 73:27). 
The reaction of β-14e (23.2 mg, 47 µmol) was performed in the same way, providing a mixture of α-14e 
and β-14e (20.7 mg, 89%, α:β = 70:30). 
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